Receipt of guideline‐concordant local and chemotherapy‐based systemic therapy for patients with triple‐negative breast cancer: 10‐year survival outcomes in a multi‐state population‐based analysis

Building on this study's methodology and its findings about the effectiveness of long-standing approaches to TNBC management, additional population-based studies are urgently needed as new therapeutic approaches are being integrated into guidelines and clinical practice.

Authors

Institutions

Publication Details

Journal
Cancer
Published
2026-02-15
DOI
https://doi.org/10.1002/cncr.70267
Citations
1
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
24.82
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Receipt of guideline‐concordant local and chemotherapy‐based systemic therapy for patients with triple‐negative breast cancer: 10‐year survival outcomes in a multi‐state population‐based analysis

Nicolas Toumbacaris, Jeffrey M. Switchenko, Xiao‐Cheng Wu, Jennifer M. Wike et al.
1 citations
Cancer
Breast Cancer Treatment Studies
24.82
article

Receipt of guideline‐concordant local and chemotherapy‐based systemic therapy for patients with triple‐negative breast cancer: 10‐year survival outcomes in a multi‐state population‐based analysis

Nicolas Toumbacaris, Jeffrey M. Switchenko, Xiao‐Cheng Wu, Jennifer M. Wike, Kevin C. Ward, Adam Currey, Rosemary D. Cress, Gretchen G. Kimmick, Joseph Lipscomb, J. Frank Wilson
article en
1 citations

Abstract

Building on this study's methodology and its findings about the effectiveness of long-standing approaches to TNBC management, additional population-based studies are urgently needed as new therapeutic approaches are being integrated into guidelines and clinical practice.

CancerVol. 132(4)
Louisiana State Department of Health and Hospitals (US), Cancer Prevention Institute of California (US), Memorial Sloan Kettering Cancer Center (US), Emory University (US), Medical College of Wisconsin (US), The Centers (US), Duke Medical Center (US), Louisiana Cancer Research Center (US), Duke Cancer Institute, Louisiana State University Health Sciences Center New Orleans (US)
Openalex Percentile: Top 1%
Breast Cancer Treatment Studies
24.82
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.